Targeting IL-5Rα with antibody-conjugates reveals a strategy for imaging and therapy for invasive bladder cancer-Reference-Cited by-同舟云学术

Targeting IL-5Rα with antibody-conjugates reveals a strategy for imaging and therapy for invasive bladder cancer

Published:2017-05-19 Issue:10 Volume:6 Page:e1331195
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Paquette Michel¹^ORCID,Vilera-Perez Luis-Guillermo²,Beaudoin Simon¹,Ekindi-Ndongo Nadia²,Boudreaut Pierre-Luc³,Bonin Marc-Andre⁴,Battista Marie-Claude⁵,Bentourkia M'hamed¹⁶⁷,Lopez Angel F.⁸,Lecomte Roger¹⁶⁷,Marsault Eric³⁷,Guérin Brigitte¹⁶⁷^ORCID,Sabbagh Robert⁹,Leyton Jeffrey V.¹⁶⁷

Affiliation:

1. Department of Nuclear Medicine and Radiobiology, Faculty of Medicine and Health Sciences (FMHS), Centre hospitalier universitaire de Sherbrooke (CHUS), Université de Sherbrooke (UdeS), Sherbrooke, Québec, Canada

2. Department of Pathology, FMHS, CHUS, UdeS, Sherbrooke, Québec, Canada

3. Department of Pharmacology and Physiology, FMHS, CHUS, UdeS, Sherbrooke, Québec, Canada

4. Peptide Chemistry Platform, UdeS, Sherbrooke, Québec, Canada

5. Division of Endocrinology, Department of Medicine and Department of Obstetrics and Gynecology, FMHS, CHUS, Sherbrooke, Québec, Canada

6. Sherbrooke Molecular Imaging Centre (SMIC), Centre de recherche du CHUS (CRCHUS), Sherbrooke, Québec, Canada

7. Sherbrooke Pharmacology Institute, Sherbrooke, Québec, Canada

8. The Centre for Cancer Biology, SA Pathology and the University of South Australia, Adelaide, South Australia, Australia

9. Department of Surgery, FMHS, CHUS, UdeS, Sherbrooke, Québec, Canada

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2017.1331195

Reference36 articles.

1. Global cancer statistics, 2012

2. Bladder cancer

3. Multimodal management of muscle-invasive bladder cancer

4. IMPACT OF THE NUMBER OF LYMPH NODES RETRIEVED ON OUTCOME IN PATIENTS WITH MUSCLE INVASIVE BLADDER CANCER

5. Current Staging Procedures in Urinary Bladder Cancer

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Local delivery of accutox® synergises with immune-checkpoint inhibitors at disrupting tumor growth;Journal of Translational Medicine;2024-06-03

2. Intratumoral administration of unconjugated Accum™ impairs the growth of pre‐established solid lymphoma tumors;Cancer Science;2023-09-29

3. Localized Nano-mediated Interleukin-12 Gene Therapy: Promising Candidate for Cancer Immunotherapeutics;Current Cancer Drug Targets;2022-10

4. Accum™ Technology: A Novel Conjugable Primer for Onco-Immunotherapy;Molecules;2022-06-13

5. EGFR-Targeted ImmunoPET of UMUC3 Orthotopic Bladder Tumors;Molecular Imaging and Biology;2022-02-11